Federica Ruffini

1.2k total citations
30 papers, 936 citations indexed

About

Federica Ruffini is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Federica Ruffini has authored 30 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Immunology and Allergy. Recurrent topics in Federica Ruffini's work include Angiogenesis and VEGF in Cancer (21 papers), Cell Adhesion Molecules Research (9 papers) and Lymphatic System and Diseases (7 papers). Federica Ruffini is often cited by papers focused on Angiogenesis and VEGF in Cancer (21 papers), Cell Adhesion Molecules Research (9 papers) and Lymphatic System and Diseases (7 papers). Federica Ruffini collaborates with scholars based in Italy, United States and Switzerland. Federica Ruffini's co-authors include Pedro Miguel Lacal, Stefania D’Atri, Grazia Graziani, Lucio Tentori, Lauretta Levati, Alessia Muzi, Annalisa Susanna Dorio, Elena Pagani, Maria Grazia Atzori and Cristina Maria Failla and has published in prestigious journals such as Blood, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Federica Ruffini

30 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Ruffini Italy	20	637	461	197	178	118	30	936
Gabriel J. Villares United States	18	666 1.0×	330 0.7×	271 1.4×	241 1.4×	124 1.1×	19	1.2k
Maya Zigler United States	17	565 0.9×	300 0.7×	184 0.9×	273 1.5×	109 0.9×	23	961
Lily Yen United States	17	861 1.4×	639 1.4×	184 0.9×	101 0.6×	80 0.7×	18	1.3k
Dhara N. Amin United States	12	782 1.2×	684 1.5×	334 1.7×	100 0.6×	66 0.6×	19	1.2k
Francesca Merchionne Italy	13	362 0.6×	251 0.5×	125 0.6×	84 0.5×	77 0.7×	21	670
Antoni X. Torres‐Collado United States	13	376 0.6×	266 0.6×	186 0.9×	309 1.7×	72 0.6×	17	870
Femke Hillen Netherlands	8	531 0.8×	349 0.8×	321 1.6×	154 0.9×	57 0.5×	9	882
Natalia Marchenko United States	17	836 1.3×	681 1.5×	423 2.1×	121 0.7×	89 0.8×	30	1.3k
Taru Muranen United States	13	555 0.9×	383 0.8×	177 0.9×	110 0.6×	81 0.7×	25	1.1k
Christophe Schneider France	19	617 1.0×	307 0.7×	242 1.2×	307 1.7×	94 0.8×	41	1.1k

Countries citing papers authored by Federica Ruffini

Since Specialization

Citations

This map shows the geographic impact of Federica Ruffini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Ruffini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Ruffini more than expected).

Fields of papers citing papers by Federica Ruffini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Ruffini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Ruffini. The network helps show where Federica Ruffini may publish in the future.

Co-authorship network of co-authors of Federica Ruffini

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Ruffini. A scholar is included among the top collaborators of Federica Ruffini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Ruffini. Federica Ruffini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ceci, Claudia, Federica Ruffini, Mattia Falconi, et al.. (2024). Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential. Biomedicine & Pharmacotherapy. 176. 116766–116766. 5 indexed citations

Ruffini, Federica, Claudia Ceci, Maria Grazia Atzori, et al.. (2023). Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors. Pharmacological Research. 192. 106782–106782. 5 indexed citations

Atzori, Maria Grazia, Claudia Ceci, Federica Ruffini, et al.. (2022). The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor. Cancers. 14(22). 5578–5578. 5 indexed citations

Lacal, Pedro Miguel, Maria Grazia Atzori, Federica Ruffini, et al.. (2020). Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma. Pharmacological Research. 159. 104957–104957. 28 indexed citations

Atzori, Maria Grazia, Claudia Ceci, Federica Ruffini, et al.. (2019). Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib. Journal of Cellular and Molecular Medicine. 24(1). 465–475. 39 indexed citations

Caporali, Simona, Adriana Amaro, Lauretta Levati, et al.. (2019). miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. Journal of Experimental & Clinical Cancer Research. 38(1). 272–272. 69 indexed citations

Atzori, Maria Grazia, Lucio Tentori, Federica Ruffini, et al.. (2017). The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. Journal of Experimental & Clinical Cancer Research. 36(1). 106–106. 42 indexed citations

Atzori, Maria Grazia, Lucio Tentori, Federica Ruffini, et al.. (2017). The Anti–Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. Journal of Pharmacology and Experimental Therapeutics. 364(1). 77–86. 24 indexed citations

Pagani, Elena, Federica Ruffini, Gian Carlo Antonini Cappellini, et al.. (2016). Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness. International Journal of Oncology. 48(4). 1581–1589. 35 indexed citations

10.

Graziani, Grazia, Federica Ruffini, Lucio Tentori, et al.. (2016). Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding. Oncotarget. 7(45). 72868–72885. 22 indexed citations

11.

Ruffini, Federica, Grazia Graziani, Lauretta Levati, et al.. (2014). Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin. International Journal of Cancer. 136(6). E545–58. 55 indexed citations

12.

Lacal, Pedro Miguel, Maria Grazia Petrillo, Federica Ruffini, et al.. (2013). Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Ligand Triggering Upregulates Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 and Promotes Leukocyte Adhesion. Journal of Pharmacology and Experimental Therapeutics. 347(1). 164–172. 26 indexed citations

13.

Ruffini, Federica, Stefania D’Atri, & Pedro Miguel Lacal. (2013). Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms. International Journal of Oncology. 43(1). 297–306. 44 indexed citations

14.

Ruffini, Federica, Lucio Tentori, Annalisa Susanna Dorio, et al.. (2013). Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. Oncology Reports. 30(6). 2887–2896. 21 indexed citations

15.

Lacal, Pedro Miguel, Veronica Morea, Federica Ruffini, et al.. (2008). Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide. European Journal of Cancer. 44(13). 1914–1921. 17 indexed citations

16.

Tentori, Lucio, Pedro Miguel Lacal, Alessia Muzi, et al.. (2007). Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis. European Journal of Cancer. 43(14). 2124–2133. 124 indexed citations

17.

Marcellini, Marcella, Naomi De Luca, Teresa Riccioni, et al.. (2006). Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor. American Journal Of Pathology. 169(2). 643–654. 82 indexed citations

18.

Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2005). Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. European Journal of Cancer. 41(18). 2948–2957. 40 indexed citations

19.

Lacal, Pedro Miguel, Federica Ruffini, Elena Pagani, & Stefania D’Atri. (2005). An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.. PubMed. 27(6). 1625–32. 60 indexed citations

20.

Tentori, Lucio, Matteo Vergati, Alessia Muzi, et al.. (2005). Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. International Journal of Oncology. 27(2). 525–35. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact